Pages that link to "Q34938584"
Jump to navigation
Jump to search
The following pages link to Rapid modelling of cooperating genetic events in cancer through somatic genome editing (Q34938584):
Displaying 50 items.
- Somatic mutations in disorders with disrupted brain connectivity (Q26747309) (← links)
- Emerging Technologies to Create Inducible and Genetically Defined Porcine Cancer Models (Q26765901) (← links)
- Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer Treatment (Q26769963) (← links)
- GEMMs as preclinical models for testing pancreatic cancer therapies (Q26781848) (← links)
- CRISPR-Cas9: A Revolutionary Tool for Cancer Modelling (Q26782773) (← links)
- Origins, genetic landscape, and emerging therapies of small cell lung cancer (Q26798218) (← links)
- Cancer Cell Line Panels Empower Genomics-Based Discovery of Precision Cancer Medicine (Q26800337) (← links)
- The CRISPR revolution and its impact on cancer research (Q26824997) (← links)
- Genome-editing technologies for gene correction of hemophilia (Q28066273) (← links)
- Using CRISPR/Cas to study gene function and model disease in vivo (Q28072587) (← links)
- Survival and Evolution of CRISPR-Cas System in Prokaryotes and Its Applications (Q28079111) (← links)
- Genetically engineered mouse models in oncology research and cancer medicine (Q28079323) (← links)
- CRISPR/Cas9: Transcending the Reality of Genome Editing (Q33632925) (← links)
- CRISPR/Cas9: From Genome Engineering to Cancer Drug Discovery (Q33772342) (← links)
- Generation and comparison of CRISPR-Cas9 and Cre-mediated genetically engineered mouse models of sarcoma (Q33899910) (← links)
- The potential of the combination of CRISPR/Cas9 and pluripotent stem cells to provide human organs from chimaeric pigs (Q34043553) (← links)
- Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma (Q34045952) (← links)
- Inducible in vivo genome editing with CRISPR-Cas9 (Q34463380) (← links)
- Applications of the CRISPR-Cas9 system in cancer biology (Q34479139) (← links)
- Precision cancer mouse models through genome editing with CRISPR-Cas9. (Q34480103) (← links)
- CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice (Q34499647) (← links)
- Applications of CRISPR-Cas9 mediated genome engineering (Q34669857) (← links)
- The putative tumor suppressor gene EphA3 fails to demonstrate a crucial role in murine lung tumorigenesis or morphogenesis. (Q35237736) (← links)
- A versatile modular vector system for rapid combinatorial mammalian genetics (Q35408740) (← links)
- A versatile reporter system for CRISPR-mediated chromosomal rearrangements. (Q35734029) (← links)
- Rapid and efficient one-step generation of paired gRNA CRISPR-Cas9 libraries (Q35747399) (← links)
- Personalized targeted therapy for esophageal squamous cell carcinoma (Q35819517) (← links)
- Capturing complex tumour biology in vitro: histological and molecular characterisation of precision cut slices (Q35863759) (← links)
- Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses. (Q35871626) (← links)
- The CRISPR road: from bench to bedside on an RNA-guided path. (Q35976998) (← links)
- The generation and characterization of novel Col1a1FRT-Cre-ER-T2-FRT and Col1a1FRT-STOP-FRT-Cre-ER-T2 mice for sequential mutagenesis (Q36090852) (← links)
- piggyBac mediates efficient in vivo CRISPR library screening for tumorigenesis in mice (Q36243531) (← links)
- Rapid tumor induction in zebrafish by TALEN-mediated somatic inactivation of the retinoblastoma1 tumor suppressor rb1 (Q36273681) (← links)
- Tissue-specific tumorigenesis: context matters (Q36296335) (← links)
- Screening for tumor suppressors: Loss of ephrin receptor A2 cooperates with oncogenic KRas in promoting lung adenocarcinoma (Q36331953) (← links)
- Preclinical Models Provide Scientific Justification and Translational Relevance for Moving Novel Therapeutics into Clinical Trials for Pediatric Cancer (Q36378105) (← links)
- PIK3CA(H1047R) Accelerates and Enhances KRAS(G12D)-Driven Lung Tumorigenesis (Q36378189) (← links)
- A Modular Assembly Platform for Rapid Generation of DNA Constructs. (Q36591466) (← links)
- Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer (Q36669793) (← links)
- Tissue Engineering and Regenerative Medicine 2015: A Year in Review (Q36756232) (← links)
- Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland (Q37051766) (← links)
- Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma (Q37123636) (← links)
- FGFR1 inhibition in lung squamous cell carcinoma: questions and controversies. (Q37164249) (← links)
- Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinoma (Q37369422) (← links)
- Rapid and tunable method to temporally control gene editing based on conditional Cas9 stabilization (Q37661378) (← links)
- CRISPR-Cas9: a new and promising player in gene therapy (Q38364993) (← links)
- Lineage factors and differentiation states in lung cancer progression (Q38395972) (← links)
- Application of CRISPR/Cas9 genome editing to the study and treatment of disease (Q38397580) (← links)
- High-Throughput Silencing Using the CRISPR-Cas9 System: A Review of the Benefits and Challenges (Q38498286) (← links)
- CRISPR-Cas9 systems: versatile cancer modelling platforms and promising therapeutic strategies (Q38516454) (← links)